China approves Sinopharm vaccine for children, teenagers


Women and a child walk by a billboard calling on people to get vaccinated against Covid-19 outside a shopping mall in Beijing, capital of China, on May 24, 2021. - AP

BEIJING (China Daily/ANN): Sinopharm's Covid-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.

The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the Covid-19 pandemic.

It is the second domestic Covid-19 vaccine made available for children and teenagers in China. In June, Sinovac Biotech's vaccine was authorised for emergency use for young people.

Sinopharm said in a statement released on Friday that it had completed the first and second stages of clinical trials in Henan province on people ages 3 to 17, which showed their vaccine was effective and safe.

All trial participants had generated antibodies to tackle the virus after receiving two doses. There were no significant differences in the strength of their immunity when compared with adult counterparts.

The vaccine showed good safety and no severe adverse effects had been recorded, the company said.

"We began clinical trials among adolescents by first testing 13- to 17-year-olds, then proceeding to 6-to 12-year-olds and 3- to 5-year-olds, so as to guarantee safety," said Zhang Yuntao, chief scientist and vice-president of Sinopharm's China National Biotech Group, during an interview with China National Radio.

The company said it also launched a study in Abu Dhabi in the United Arab Emirates on June 6, to evaluate the vaccine's efficacy in a group of 900 people of different nationalities ages 3 to 17.

Vaccinating children and teens is essential to building an immunity barrier against the virus, Zhang said. Young people's immune systems are still developing, so researchers are careful when involving them in clinical trials, he said.

Zhang said it will likely take another year for the vaccine to receive full market approval from the nation's top drug regulator for use in younger people.

Sinovac also reported encouraging results from the first and second stage clinical trials of its vaccine on 552 people ages 3 to 17 in Hebei province, conducted from October to December.

According to results published in The Lancet medical journal in late June, its vaccine had elicited antibody responses in over 96 per cent of trial participants, on par with the rate in trials involving adults.

Liu Peicheng, a spokesman for Sinovac, said the vaccines administered to children and teens are identical to those delivered to adults.

"There is no need to take extra precautions when inoculating children," he added.

Last week, several cities in the Guangxi Zhuang autonomous region and Fujian and Hebei provinces announced they will begin administering Covid-19 vaccines to teenagers ages 12 to 17, with some cities saying they will complete the inoculations by the end of September or October.

Since then, more than a dozen provincial-level regions have announced similar plans.

Beijing is taking surveys and rolling out publicity campaigns in preparation for the start of its vaccination programme for teenagers after September, community workers told the newspaper Health Times. - China Daily/Asia News Network

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

China , covid-19 , vaccine , Sinopharm , children , teenagers , approval

   

Next In Aseanplus News

917 new Covid-19 cases in Singapore; 2 local men aged 84 and 85 die from complications
Bangkok remains the epicentre in Thailand's Covid-19 fight after logging in 2,880 cases on Monday (Sept 20)
Indonesia logs fewest daily Covid-19 cases in over a year; only 1,932 confirmed cases on Monday (Sept 21)
Philippines: Delta Variant cases are increasing as country logs 18,937 new Covid-19 cases, death toll nears 37,000 on Monday (Sept 20)
Vietnam reports 8,681 new Covid-19 cases on Monday (Sept 20), lowest in month
South Korea beats Singapore to clinch top innovation spot in Asia with K-pop power
Indonesia cracks down on tax evasion in bid to boost government revenues
Thailand to step up mass testing at Phuket as Covid-19 cases continue to rise in resort island
Duterte drug war enforcer says prefers to be 'hanged' in the Philippines
'We were them:' Vietnamese Americans help Afghan refugees

Stories You'll Enjoy


Vouchers